CLINICAL_TRIALS
trial_result
· 2017-12-02
Clinical Trial Update: Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating the safety and potential antitumor effects of atorvastatin in Non-Hodgkin lymphoma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dean Felsher | Conditions: Leukemia, Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2017-12-02